In the context of this review, HIES patients have a much higher risk of developing aggressive B cell lymphomas, which may be linked to abnormalities in STAT3/IL-21-dependent differentiation of B cells into plasma cells with the possible involvement of T follicular helper cells (82–84). This evidence concerns the gene STAT3 and hyper-IgE syndrome.